Literature DB >> 8893829

Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists.

C Chen1, R Dagnino, E B De Souza, D E Grigoriadis, C Q Huang, K I Kim, Z Liu, T Moran, T R Webb, J P Whitten, Y F Xie, J R McCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8893829     DOI： 10.1021/jm960149e

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  21 in total

1.  Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.

Authors:  Supriyo Bhattacharya; Govindan Subramanian; Spencer Hall; Jianping Lin; Abdelazize Laoui; Nagarajan Vaidehi
Journal:  J Comput Aided Mol Des       Date:  2010-05-29       Impact factor: 3.686

2.  Nonpeptidic glucagon-like peptide 1 receptor agonists: a magic bullet for diabetes?

Authors:  K G Murphy; S R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

4.  Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

Authors:  A Rühmann; I Bonk; C R Lin; M G Rosenfeld; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.

Authors:  Shunske Tanahashi; Satoshi Yamamura; Masanori Nakagawa; Eishi Motomura; Motohiro Okada
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.

Authors:  T Z Baram; D T Chalmers; C Chen; Y Koutsoukos; E B De Souza
Journal:  Brain Res       Date:  1997-10-03       Impact factor: 3.252

8.  Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress.

Authors:  Sayamwong E Hammack; Megan J Schmid; Matthew L LoPresti; Andre Der-Avakian; Mary Ann Pellymounter; Alan C Foster; Linda R Watkins; Steven F Maier
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.

Authors:  Thomas L Kash; William P Nobis; Robert T Matthews; Danny G Winder
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

10.  Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis.

Authors:  Walter Francesconi; Fulvia Berton; Vez Repunte-Canonigo; Kazuki Hagihara; David Thurbon; Dusan Lekic; Sheila E Specio; Thomas N Greenwell; Scott A Chen; Kenner C Rice; Heather N Richardson; Laura E O'Dell; Eric P Zorrilla; Marisela Morales; George F Koob; Pietro Paolo Sanna
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.